ONCLIVE NEWS NETWORK: ON LOCATION WILL BE LIVE AT ESMO THIS WEEK - STAY TUNED FOR MORE INFORMATION!

Dr. Gomella on Labeling Low-Risk Prostate Cancer

Leonard G. Gomella, MD
Published: Friday, Dec 26, 2014



Leonard Gomella, MD, chair, Department of Urology, director, Kimmel Cancer Center Network, Thomas Jefferson University Hospital, talks about the challenge of treating prostate cancer patients with a Gleason score of less than six.

Active surveillance is an appropriate treatment for the majority of those with Gleason six prostate cancer, but often the term ‘cancer’ makes patients feel like they need more aggressive treatment.

Overtreatment is a common problem, which may be solved by renaming the disease, says Gomella.
 


Leonard Gomella, MD, chair, Department of Urology, director, Kimmel Cancer Center Network, Thomas Jefferson University Hospital, talks about the challenge of treating prostate cancer patients with a Gleason score of less than six.

Active surveillance is an appropriate treatment for the majority of those with Gleason six prostate cancer, but often the term ‘cancer’ makes patients feel like they need more aggressive treatment.

Overtreatment is a common problem, which may be solved by renaming the disease, says Gomella.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x